Business Daily from THE HINDU group of publications
Wednesday, Oct 15, 2008
ePaper | Mobile/PDA Version | Audio | Blogs

News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Mergers & Acquisitions
Get Latest Quote and Company Info
Ranbaxy-Daiichi Sankyo deal to be completed by Dec

Our Bureau

New Delhi, Oct. 14 Ranbaxy Pharmaceuticals on Tuesday said the agreement with the Japanese pharma major Daiichi Sankyo will be completed in the next one month.

Ranbaxy’s Chief Executive Officer and Managing Director, Mr Malvinder Mohan Singh, said the acquisition by the Japanese company will be completed by December. The deal includes Daiichi buying promoters’ stake in Ranbaxy, acquisition of 20 per cent of company’s equity capital through an open offer to shareholders and issue of warrants and shares on a preferential basis. Mr Singh also said the company is continuing its dialogue with the US drug regulator to ensure that the ban on import of its drugs is lifted.

“We are doing our best and responding to every issue being raised by the FDA. We remain confident about the efficacy of our drugs and hope will be able to convince the FDA soon,” he told reporters on the sidelines of a seminar on trilateral trade between India, Brazil and South Africa.

Despite the ban by the US authorities, Daiichi Sankyo said it will go ahead with the earlier announced deal to acquire Ranbaxy’s shares at Rs 737 even as the Indian company’s market capitalisation fell to one-third of the June offer.

The Japanese company said it will follow accounting standards to determine valuation losses if Ranbaxy’s share price continues to spiral downwards.

Related Stories:
Daiichi Sankyo-Ranbaxy deal gets Govt clearance
Ranbaxy open offer: Excess shares to be returned by today
Ranbaxy open offer: Excess shares to be returned by today

More Stories on : Mergers & Acquisitions | Ranbaxy Laboratories Ltd | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page




Stories in this Section
Dr Reddy’s arm launches dermatology product in US


Zydus vaccine gets WHO nod
Ranbaxy-Daiichi Sankyo deal to be completed by Dec
Buy gives Tata Motors electric vehicles tech prowess
Tata Motors buys majority stake in Norwegian firm
GMR acquires 50% in InterGen
NDTV Lumière offers world movies on a platter
Jet-Kingfisher deal: May not boost pricing power
Alliance will ‘ensure realistic fares’: Paramount
Tie-up could reduce overcapacity in the sector
Kingfisher-Jet alliance to improve the duo’s margins
Gujarat NRE Coke’s Australian arm on growth track
Abmak service apartments in Thrissur
GE gears up for civil nuclear play




Smartbuy



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line